These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2454175)

  • 61. The third (C3) and the fourth (C4) components of complement: labile binding site and covalent bond formation.
    Janatova J
    Ann N Y Acad Sci; 1983; 421():218-34. PubMed ID: 6586100
    [No Abstract]   [Full Text] [Related]  

  • 62. C3, C4 and C5: the thioester site.
    Law SK; Dodds AW
    Biochem Soc Trans; 1990 Dec; 18(6):1155-9. PubMed ID: 2088831
    [No Abstract]   [Full Text] [Related]  

  • 63. Covalent binding efficiency of the third and fourth complement proteins in relation to pH, nucleophilicity, and availability of hydroxyl groups.
    Law SK; Minich TM; Levine RP
    Biochemistry; 1984 Jul; 23(14):3267-72. PubMed ID: 6432041
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The covalent binding reaction of complement component C3.
    Gadjeva M; Dodds AW; Taniguchi-Sidle A; Willis AC; Isenman DE; Law SK
    J Immunol; 1998 Jul; 161(2):985-90. PubMed ID: 9670979
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Mouse complement component C4 is devoid of classical pathway C5 convertase subunit activity.
    Ebanks RO; Isenman DE
    Mol Immunol; 1996 Feb; 33(3):297-309. PubMed ID: 8649451
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Sensitivity of antiproteases, complement factors and C-reactive protein in detecting pancreatic necrosis. Results of a prospective clinical study.
    Büchler M; Malfertheiner P; Schoetensack C; Uhl W; Beger HG
    Int J Pancreatol; 1986 Oct; 1(3-4):227-35. PubMed ID: 2445867
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A monoclonal antibody which can distinguish between the two isotypes of human C4.
    Hsiung LM; Mason DW; Dodds AW
    Mol Immunol; 1987 Jan; 24(1):91-6. PubMed ID: 3614207
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
    Brown EJ; Ramsey J; Hammer CH; Frank MM
    J Immunol; 1983 Jul; 131(1):403-8. PubMed ID: 6602833
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Molecular interactions between MASP-2, C4, and C2 and their activation fragments leading to complement activation via the lectin pathway.
    Wallis R; Dodds AW; Mitchell DA; Sim RB; Reid KB; Schwaeble WJ
    J Biol Chem; 2007 Mar; 282(11):7844-51. PubMed ID: 17204478
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Human alpha2-macroglobulin is composed of multiple domains, as predicted by homology with complement component C3.
    Doan N; Gettins PG
    Biochem J; 2007 Oct; 407(1):23-30. PubMed ID: 17608619
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Separation of different forms of the fourth component of human complement by fast protein liquid chromatography.
    Hessing M; Paardekooper J; Hack CE
    J Immunol Methods; 1993 Jan; 157(1-2):39-48. PubMed ID: 8423373
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Binding of recombinant interleukin-1 beta to the third complement component and alpha 2-macroglobulin after activation of serum by immune complexes.
    Borth W; Urbanski A; Prohaska R; Susanj M; Luger TA
    Blood; 1990 Jun; 75(12):2388-95. PubMed ID: 1693530
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A study of a covalent-like interaction between soluble nascent C4b and C4-binding protein.
    Villiers MB; Thielens NM; Reboul A; Colomb MG
    Biochim Biophys Acta; 1982 Jun; 704(2):197-203. PubMed ID: 6980671
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Third component of human complement: localization of the internal thiolester bond.
    Thomas ML; Janatova J; Gray WR; Tack BF
    Proc Natl Acad Sci U S A; 1982 Feb; 79(4):1054-8. PubMed ID: 6175959
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Molecular basis of complement resistance of human melanoma cells expressing the C3-cleaving membrane protease p65.
    Ollert MW; Kadlec JV; Petrella EC; Bredehorst R; Vogel CW
    Cancer Res; 1993 Feb; 53(3):592-9. PubMed ID: 8425193
    [TBL] [Abstract][Full Text] [Related]  

  • 76. alpha2-Macroglobulin from hemolymph of the freshwater crayfish Astacus astacus.
    Stöcker W; Breit S; Sottrup-Jensen L; Zwilling R
    Comp Biochem Physiol B; 1991; 98(4):501-9. PubMed ID: 1714366
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Covalent binding of C3b to C4b within the classical complement pathway C5 convertase. Determination of amino acid residues involved in ester linkage formation.
    Kim YU; Carroll MC; Isenman DE; Nonaka M; Pramoonjago P; Takeda J; Inoue K; Kinoshita T
    J Biol Chem; 1992 Feb; 267(6):4171-6. PubMed ID: 1740458
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Alternative complement pathway activation by C4b deposited during classical pathway activation.
    Matsushita M; Okada H
    J Immunol; 1986 Apr; 136(8):2994-8. PubMed ID: 2937839
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The covalent binding story of the complement proteins C3 and C4 (I) 1972-1981.
    Law SKA; Levine RP
    Immunobiology; 2019 Nov; 224(6):827-833. PubMed ID: 31445811
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Fourth component of Xenopus laevis complement: cDNA cloning and linkage analysis of the frog MHC.
    Mo R; Kato Y; Nonaka M; Nakayama K; Takahashi M
    Immunogenetics; 1996; 43(6):360-9. PubMed ID: 8606056
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.